NUVB vs. LLY
Compare and contrast key facts about Nuvation Bio Inc. (NUVB) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NUVB or LLY.
Correlation
The correlation between NUVB and LLY is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NUVB vs. LLY - Performance Comparison
Key characteristics
NUVB:
0.36
LLY:
0.40
NUVB:
1.31
LLY:
0.77
NUVB:
1.14
LLY:
1.10
NUVB:
0.36
LLY:
0.51
NUVB:
1.10
LLY:
1.18
NUVB:
28.44%
LLY:
10.53%
NUVB:
87.72%
LLY:
30.89%
NUVB:
-93.38%
LLY:
-68.27%
NUVB:
-84.42%
LLY:
-8.74%
Fundamentals
NUVB:
$774.10M
LLY:
$779.75B
NUVB:
-$2.18
LLY:
$11.74
NUVB:
$2.43M
LLY:
$45.04B
NUVB:
-$1.00M
LLY:
$36.76B
NUVB:
-$523.35M
LLY:
$15.63B
Returns By Period
In the year-to-date period, NUVB achieves a -14.66% return, which is significantly lower than LLY's 13.29% return.
NUVB
-14.66%
-12.02%
-18.93%
27.53%
N/A
N/A
LLY
13.29%
17.82%
-8.18%
17.81%
45.73%
30.99%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NUVB vs. LLY — Risk-Adjusted Performance Rank
NUVB
LLY
NUVB vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nuvation Bio Inc. (NUVB) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NUVB vs. LLY - Dividend Comparison
NUVB has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.62%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NUVB Nuvation Bio Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.62% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
Drawdowns
NUVB vs. LLY - Drawdown Comparison
The maximum NUVB drawdown since its inception was -93.38%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for NUVB and LLY. For additional features, visit the drawdowns tool.
Volatility
NUVB vs. LLY - Volatility Comparison
Nuvation Bio Inc. (NUVB) has a higher volatility of 14.93% compared to Eli Lilly and Company (LLY) at 7.17%. This indicates that NUVB's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NUVB vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Nuvation Bio Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities